Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
Cancer Treatment Reviews
|
December 7, 2010
Update on capecitabine alone and in combination regimens in colorectal cancer patients
N Silvestris, E Maiello, F De Vita, et al.
Cancer Chemotherapy and Pharmacology
|
June 8, 2001
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
M Donadio, E Manzin, A Berruti, et al.
European Journal of Cancer Care
|
August 17, 2013
Patients attitudes towards sleep disturbances during chemotherapy
F Romito, C Cormio, S De Padova, et al.
Journal of Colloid and Interface Science
|
August 1, 2024
Intrinsic dynamics of emulsions: Experiments in microgravity on the International Space Station
V Lorusso, D Orsi, M Vaccari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
G Frasci, V Lorusso, N Panza, et al.
Atherosclerosis
|
June 8, 2001
Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound
G Chiesa, C Di Mario, N Colombo, et al.
British Journal of Cancer
|
June 16, 2005
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F Cappuzzo, S Novello, F De Marinis, et al.
International Journal of Oncology
|
December 22, 1999
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group
V Lorusso, G Palmieri, A R Bianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial
P Comella, B Massidda, G Filippelli, et al.
Gynecologic Oncology
|
March 26, 1998
Combined carboplatin plus ifosfamide and cisplatin in patients with advanced ovarian carcinoma. A phase I-II study. GOCS (Gynecological Oncology Cooperative Study)
V Lorusso, B Leone, G Di Vagno, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
Cancer Treatment Reviews
|
December 7, 2010
Update on capecitabine alone and in combination regimens in colorectal cancer patients
N Silvestris, E Maiello, F De Vita, et al.
Cancer Chemotherapy and Pharmacology
|
June 8, 2001
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
M Donadio, E Manzin, A Berruti, et al.
European Journal of Cancer Care
|
August 17, 2013
Patients attitudes towards sleep disturbances during chemotherapy
F Romito, C Cormio, S De Padova, et al.
Journal of Colloid and Interface Science
|
August 1, 2024
Intrinsic dynamics of emulsions: Experiments in microgravity on the International Space Station
V Lorusso, D Orsi, M Vaccari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2000
Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer
G Frasci, V Lorusso, N Panza, et al.
Atherosclerosis
|
June 8, 2001
Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound
G Chiesa, C Di Mario, N Colombo, et al.
British Journal of Cancer
|
June 16, 2005
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer
F Cappuzzo, S Novello, F De Marinis, et al.
International Journal of Oncology
|
December 22, 1999
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group
V Lorusso, G Palmieri, A R Bianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial
P Comella, B Massidda, G Filippelli, et al.
Gynecologic Oncology
|
March 26, 1998
Combined carboplatin plus ifosfamide and cisplatin in patients with advanced ovarian carcinoma. A phase I-II study. GOCS (Gynecological Oncology Cooperative Study)
V Lorusso, B Leone, G Di Vagno, et al.
Page
of 18